4Palamarchuk A, Zanesi N, Aqeilan RI, et al. Tall transgenic expression reveals absence of B lymphocytes[J]. Cancer Res,2006 66:6014-6017.
5F Manilyn LS, Kenneth JK, Peter AC, et al. Karyotypic analysis predicts outcome of preremission: a Southwest Oncology Group/Eastern Cooperative Oncology Group study [J]. Blood, 2000,96:4075-4083.
6Dupret C, ASANFI V, Leboeuf D,et al. IgH/TCR rearrangements are common in MLL translocated adult AML and suggest an early T/myeloid or B/myeloid maturation arrest, which correlates with the MLL partner[J]. Leukemia,2005 19:2337-2338.
7Roumier C,Eclache V,Imbert M, et al. MO AML,clinical and biologic features of the disease,including AML1 gene mutations : a report of 59 cases by the Groupe Fran? ais d Hematologie Cellulaire (GFHC) and the Groupe Fran? ais de Cytogenetique Hematologique (GFCH)[J]. Blood ,2003,101:1277-1283.
3David G, Andrea B, Marie J M, et al Characterization of acute promyelocytic leukemia cases lacking the classic t( 15;17): results of European Working Party[J]. Blood, 2000,96:1297 - 1308.
4Manilyn LS, Kenneth JK, Peter AC, et al, Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study[J]. Blood, 2000, 96:4075 -4083.
5Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization Classification of hematologic malignancies[J].Mod Pathol, 2000, 13:193 - 196.
6Mitelman F. Guidelines for Cancer Cytogenetics[M]. New York : Karger, 1995.
3Chen B, Wang YY, Shen Y, et al. Newly diagnosed acute lymphoblastic leukemia in China ( I ) : Abnormal genetic patterns in 1346 childhood and adult cases and their comparison with the reports from Western countries [ J ]. Leukemia, 2012,26 ( 7 ) : 1608 - 1616.
4Gao C, Zhao XX, Li WJ, et al. Clinical features, early treatment respon- ses, and outcomes of pediatric acute lymphoblastic leukemia in china with or without specific fusion transcripts:A single institutional study of 1,004 patients[ J]. Am J Hemato1,2012,87( 11 ) : 1022 - 1027.
5Pals AP, Amare Kadam PS, Raje GC, et al. RUNX1 aberrations in ETV6/ RUN'X1 - positive and ETV6/RUNX1 - negative patients : Its hemato - pathological and prognostic significance in a large cohort (619 cases) of ALL [ J 1. Pediatr Hematol 0ncol,2008,25 ( 6 ) :582 - 597.
6Contento - Gonzalo A, Jimenez - Velazco A, Alcala - Peaa M, et al. In- fluence of the fusion gene ETV6 - RUNX1 in the prognosis of the pediatric B -precursor acute lymphoblastic leukemia[ J ]. Blood,2011, 118(9) :2515.
7Beillard E, Pallisgaard N, van der Velden VH, et al. Evaluation of candi- date control genes for diagnosis and residual disease detection in leuke- mic patients using real - time quantitative reverse - transcriptase poly- merase chain reaction ( RQ - PCR) - a Europe against cancer program [ J ]. Leukemia,2003,17 ( 12 ) :2474 - 2486.
8Gabert J, Beillard E, van der Velden VH,et al. Standardization and qua- lity control studies of real - time quantitative reverse transcriptase poly- merase chain reaction of fusion gene transcripts for residual disease de- tection in leukemia - a Europe Against Cancer program [ J ]. Leuke- mia,2003,17(12) :2318 -2357.
9Hong D, Gupta R, Ancliff P, et al. Initiating and cancer - propagating cells in TEL - AMLI - associated childhood leukemia [ J ]. Science, 2008,319:336 - 339.
10Zuna J, Madzo J, Krejci O, et al. ETV6/RUNX1 ( TEL/AML1 ) is a frequent prenatal first hit in childhood leukemia [ J ]. Blood, 2011,117 (1) :368 -369.
